Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

NCT06024564 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2025-01-01

No results posted yet for this study

Summary

Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion

Conditions

  • Nasal Congestion

Interventions

DEVICE

Sonu Acoustic Resonance Therapy

Participants will receive Sonu treatment twice a day for 90 days

Sponsors & Collaborators

  • Third Wave Therapeutics

    lead INDUSTRY

Principal Investigators

  • Jacob Johnson, MD · San Francisco Otolaryngology Medical Group

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-08
Primary Completion
2024-05-31
Completion
2024-08-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06024564 on ClinicalTrials.gov